Travere Therapeutics (TVTX) FCF Margin (QoQ) (2014 - 2026)
Travere Therapeutics (TVTX) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 5.25 Bn | 5.25 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,448.00 |
| Dec 31, 2025 | -5,269.00 |
| Sep 30, 2025 | 3,109.00 |
| Jun 30, 2025 | 5,598.00 |
| Mar 31, 2025 | -338.00 |
| Dec 31, 2024 | 1,876.00 |
| Sep 30, 2024 | 770.00 |
| Jun 30, 2024 | 21,268.00 |
| Mar 31, 2024 | -3,031.00 |
| Dec 31, 2023 | -9,763.00 |
| Sep 30, 2023 | 135.00 |
| Jun 30, 2023 | 16,063.00 |
| Mar 31, 2023 | -13,508.00 |
| Dec 31, 2022 | -4,551.00 |
| Sep 30, 2022 | -1,223.00 |
| Jun 30, 2022 | 10,825.00 |
| Mar 31, 2022 | -29,276.00 |
| Dec 31, 2021 | 942.00 |
| Sep 30, 2021 | 3,478.00 |
| Jun 30, 2021 | 7,703.00 |